iBio (IBIO) Short Interest Ratio & Short Volume $2.67 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsShort Interest iBio Short Interest DataiBio (IBIO) has a short interest of 307,800 shares, representing 3.38% of the float (the number of shares available for trading by the public). This marks a 123.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 1.22 million shares to cover all short positions.Current Short Interest307,800 sharesPrevious Short Interest137,700 sharesChange Vs. Previous Month+123.53%Dollar Volume Sold Short$0.00Short Interest Ratio2.6 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares3,480,000 sharesFloat Size9,120,000 sharesShort Percent of Float3.38%Today's Trading Volume38,113 sharesAverage Trading Volume1,223,659 sharesToday's Volume Vs. Average3% Short Selling iBio? Sign up to receive the latest short interest report for iBio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIBIO Short Interest Over TimeIBIO Days to Cover Over TimeIBIO Percentage of Float Shorted Over Time Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration. Watch this new documentary and you’ll discover what Elon knows, iBio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024307,800 shares $0.00 +123.5%3.4%2.6 $0.00 9/30/2024137,700 shares $0.00 +60.3%1.6%1.3 $0.00 9/15/202485,900 shares $0.00 -4.5%1.0%1.4 $0.00 8/31/202489,900 shares $0.00 +13.2%1.0%1.2 $0.00 8/15/202479,400 shares $0.00 +4.2%0.9%0.7 $0.00 7/31/202476,200 shares $0.00 -24.5%0.9%0.6 $0.00 7/15/2024100,900 shares $0.00 +11.4%1.2%0.7 $0.00 6/30/202490,600 shares $0.00 -32.5%1.1%0.4 $0.00 6/15/2024134,300 shares $0.00 +40.6%1.6%0 $0.00 5/31/202495,500 shares $0.00 +18.5%1.1%0 $0.00 5/15/202480,600 shares $0.00 -40.4%0.9%0 $0.00 4/30/2024135,200 shares $0.00 -26.7%1.6%0 $0.00 4/15/2024184,500 shares $0.00 +14.1%2.2%0 $0.00 3/31/2024161,700 shares $0.00 +172.7%1.9%0 $0.00 3/15/202459,300 shares $0.00 -44.7%1.7%0.6 $0.00 2/29/2024107,200 shares $0.00 +665.7%3.1%0.7 $0.00 2/15/202414,000 shares $0.00 +204.4%0.4%0.1 $0.00 IBIO Short Interest - Frequently Asked Questions What is iBio's current short interest? Short interest is the volume of iBio shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 307,800 shares of IBIO short. 3.38% of iBio's shares are currently sold short. Learn More on iBio's current short interest. What is a good short interest ratio for iBio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBIO shares currently have a short interest ratio of 3.0. Learn More on iBio's short interest ratio. What is a good short interest percentage for iBio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.38% of iBio's floating shares are currently sold short. Is iBio's short interest increasing or decreasing? iBio saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 307,800 shares, an increase of 123.5% from the previous total of 137,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is iBio's float size? iBio currently has issued a total of 3,480,000 shares. Some of iBio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. iBio currently has a public float of 9,120,000 shares. How does iBio's short interest compare to its competitors? 3.38% of iBio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to iBio: NextCure, Inc. (0.35%), Protara Therapeutics, Inc. (11.25%), Equillium, Inc. (1.25%), Quince Therapeutics, Inc. (5.95%), Lantern Pharma Inc. (2.21%), BioLineRx Ltd. (0.78%), Passage Bio, Inc. (3.28%), Elevation Oncology, Inc. (11.90%), Lexaria Bioscience Corp. (1.71%), Clene Inc. (2.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short iBio stock? Short selling IBIO is an investing strategy that aims to generate trading profit from iBio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against iBio? A short squeeze for iBio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IBIO, which in turn drives the price of the stock up even further. How often is iBio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBIO, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies NXTC Short Interest Data TARA Short Interest Data EQ Short Interest Data QNCX Short Interest Data LTRN Short Interest Data BLRX Short Interest Data PASG Short Interest Data ELEV Short Interest Data LEXX Short Interest Data CLNN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:IBIO) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.